Takashi
Furuyashiki
*a,
Hiroki
Takata
a,
Iwao
Kojima
a,
Takashi
Kuriki
a,
Itsuko
Fukuda
b and
Hitoshi
Ashida
bc
aInstitute of Health Sciences, Ezaki Glico Co., Ltd., 4-6-5, Utajima, Nishiyodogawa-ku, Osaka, Japan 555-8502. E-mail: furuyashiki-takashi@glico.co.jp; takata-hiroki@glico.co.jp; kojima-iwao@glico.co.jp; kuriki-takashi@glico.co.jp
bResearch Center for Food Safety and Security, Graduate School of Agricultural Science, Kobe University, 1-1 Rokkodai-cho, Nada-ku, Kobe, Hyogo, Japan 657-8501. E-mail: itsuko@silver.kobe-u.ac.jp; ashida@kobe-u.ac.jp
cDepartment of Agrobioscience, Graduate School of Agricultural Science, Kobe University, 1-1 Rokkodai-cho, Nada-ku, Kobe, Hyogo, Japan 657-8501
First published on 26th January 2011
We developed a new process for enzymatically synthesized glycogen (ESG), which is equivalent in physicochemical properties to natural-source glycogen (NSG) except its resistant property to degradation by α-amylase in vitro. In this study the metabolic fates of orally administered ESG in rats were investigated by a single oral administration test and a 2 week ingestion test. The glycemic index of ESG was 79. After the 2 week ingestion of ESG, the cecal content and production of short chain fatty acids were significantly increased, the pH value of cecal content was lowered, and the counts of Bifidobacterium and Lactobacillus in feces were significantly increased. Additionally, plasma levels of triacylglycerol and total cholesterol were significantly reduced by ESG. In contrast, NSG did not affect these parameters at all. The results collectively suggest that around 20% of orally administered ESG was transferred to the cecum in the form of polymer and assimilated into short chain fatty acids by microbiota and the polymer affected lipid metabolism.
Our group recently developed an in vitro method to synthesize glycogen from starch using isoamylase (EC 3.2.1.68), branching enzyme (EC 2.4.1.18), and amylomaltase (EC 2.4.1.25).5 The enzymatically synthesized glycogen (ESG) is equivalent to natural-source glycogen (NSG) in structural parameters, physicochemical properties, and molecular shape.5,6 In an in vitro test, treatment of ESGs with excess α-amylase resulted in the formation of high molecular weight resistant fractions (>1000 kDa) in a roughly 40% yield even after prolonged reaction. However, the content and size of the resistant fractions of NSGs were found to vary: 1 of 6 NSGs possessed high molecular weight resistant fractions, as do ESGs, but the others showed only small resistant fractions (<10 kDa) such as branched oligosaccharides.7 Evaluation of ESG by the AOAC method 2002-02 revealed that it contains about 20% of dietary fiber content.7
Dietary fiber is defined as carbohydrate polymers that are neither digested nor absorbed in the small intestine, and which have beneficial physiological effects in humans. The benefits of dietary fiber ingestion are well studied and many effects have been clarified: some soluble dietary fibers reduce plasma cholesterol levels, especially LDL cholesterol, while insoluble dietary fibers are known to increase the bulk of feces.8,9 Dietary fibers such as oligofructose, inulin, and resistant starch have been reported to function as prebiotics, which increase intestinal bifidobacteria in animals and humans.10–12 Moreover, it has been suggested that appropriate consumption of dietary fiber reduces the risk of some diseases, including cardiovascular diseases, colorectal cancer, and diabetes mellitus.13–15
In this study, the metabolic fate of orally administered ESG and the effects of ESG ingestion on intestinal fermentation and lipid metabolism were investigated in rats. In order to elucidate the role of the molecular size of digestion-resistant fractions, the effect of ingestion of NSG from mussel, which had the smallest resistant fractions among the 6 types of NSG tested previously in vitro, were also studied.
Experiment 2: for the 2 week ingestion test, 21 rats were divided into 3 groups of 7 rats each with approximately equal average body weights. The rats were housed in plastic cages and fed the control, high, or low ESG diets as shown in Table 2 for 2 weeks. During the feeding period, body weight and food intake were measured every 2–3 days. A few fresh fecal pellets excreted on day 10 were used for analyzing fecal microbiota and all feces excreted on days 11 and 12 were collected to determine α-glucan content. At the end of the 2 week feeding, the rats were euthanized under anesthesia without fasting; subsequently, their livers were removed and weighed, and the epididymal fat and cecal contents were collected.
Diet group | |||
---|---|---|---|
Control | High ESG | Low ESG | |
a Mineral mix and vitamin mix were the AIN93 composition obtained from Oriental Yeast Co., Ltd. (Tokyo, Japan). | |||
α-Corn starch | 63 | — | 47.2 |
ESG | — | 63 | 15.8 |
Casein | 20 | 20 | 20 |
Cellulose | 5 | 5 | 5 |
Corn oil | 5 | 5 | 5 |
Mineral mixa | 5 | 5 | 5 |
Vitamin mixa | 2 | 2 | 2 |
Calorie (kcal per 100 g) | 377 | 377 | 377 |
Experiment 3: to compared ESG and NSG, we substituted NSG from mussel for ESG in the high ESG group diet (Table 2). Twenty one rats were divided into 3 groups of 7 rats each with approximately equal average body weights, then rats were fed control, high ESG or high NSG diets for 2 weeks under the same conditions as Experiment 2.
Experiment 4: to evaluate the effect of ESG on plasma lipids, 14 rats were divided into 2 groups of 7 rats. The rats were housed in plastic cages and fed with the control or high ESG diets as shown in Table 2 for 2 weeks. After 6 h of fasting, rats were euthanized under anesthesia, blood samples were collected from the heart, and plasma concentrations of triacylglycerol, total cholesterol, HDL cholesterol, and non-esterified fatty acids (NEFA) were measured using the relevant commercial kits purchased from Wako.
The excretion rate of α-glucan in the feces was estimated by the following calculation: (total amount of daily feces) × (fecal concentration of α-glucan)/(total daily intake of α-glucan).
Fig. 1 Plasma glucose and insulin concentration in glucose-treated and ESG-treated rats. Rats were administered glucose (control) or ESG at a dosage of 2 g per kg body weight. Before administration and then at 10, 20, 30, and 60 min after, blood samples were collected and centrifuged to obtain plasma. Concentrations of glucose (A) and insulin (C) were determined. Closed circles and squares indicate control and ESG-treated rats, respectively. The glycemic index was calculated and is shown in B. Values are mean ± S.D.; n = 7. Asterisks indicate significant difference from the control group: *p < 0.05. |
Diet group | |||
---|---|---|---|
Control | High ESG | Low ESG | |
a Values are mean ± S D; n = 7. b The means in each row with different superscript letters are significantly different (p < 0.05). | |||
Body weight gain (g) | 95.4 ± 8.4b | 85.1 ± 9.6a | 96.7 ± 8.5b |
Food intake (g day−1/7 rats) | 109 ± 10 | 103 ± 12 | 111 ± 9 |
Organ weight (% of body weight) | |||
Liver | 4.06 ± 0.38 | 4.12 ± 0.25 | 4.20 ± 0.38 |
Epididymal fat | 1.41 ± 0.25b | 1.15 ± 0.17a | 1.42 ± 0.20b |
The quantity of cecal content increased significantly in the high ESG group compared with the control (p < 0.0001) (Fig. 2A); the cecal content of the low ESG group was 127% of that of the control group, but this change was not statistically significant. The pH of cecal content in both high ESG (7.27) and low ESG groups (7.61) was significantly lower (p < 0.0001 and p = 0.0008, respectively) than that in the control group (8.14) (Fig. 2B).
Fig. 2 Weight and pH value of cecal content were altered by ESG ingestion. Rats were fed high or low ESG diets for 2 weeks. The cecal content was weighed (A) and pH (B) measured, as described in the materials and methods section. Values are mean ± S.D.; n = 7. Bars with different letters are significantly different from each other (p < 0.05). |
Since these changes suggested modification of the fermentation in the cecum by ESG ingestion, the major fecal microbes were analyzed (Table 4). Although there were no changes in the counts of Bacteroidaceae, Enterobacteriaceae, Streptococcus or Staphylococcus, the viable counts of Bifidobacterium and Lactbacillus in the high ESG group were significantly increased compared to the control group (p < 0.0001 and p = 0.0065).
Diet group | |||
---|---|---|---|
Control | High ESG | Low ESG | |
a Values are mean ± S D; n = 7. b The means in each row with different superscript letters are significantly different (p < 0.05). | |||
log10 per g wet feces | |||
Bifidobacterium | 7.1 ± 0.66a | 10.7 ± 0.25b | 7.8 ± 1.30a |
Bacteroidaceae | 9.5 ± 0.48 | 9.7 ± 0.52 | 9.5 ± 0.21 |
Enterobacteriaceae | 6.8 ± 0.66 | 6.4 ± 0.43 | 6.4 ± 0.43 |
Streptococcus | 7.4 ± 0.71 | 6.7 ± 0.57 | 7.1 ± 0.45 |
Staphylococcus | 6.0 ± 0.44 | 4.4 ± 0.92 | 5.9 ± 0.60 |
Lactobacillus | 7.6 ± 0.43a | 9.1 ± 0.45b | 8.4 ± 0.43a |
It is recognized that changes in fermentation often result in increases in short-chain fatty acids (SCFAs). To clarify this point, the concentrations of acetate, propionate, and butyrate in the cecal contents were determined by GLC analysis (Fig. 3). In the high ESG group, the amounts of acetate, propionate, and butyrate were significantly increased to 269% (p = 0.0002), 516% (p < 0.0001), and 766% (p = 0.0006), respectively, of those in the control group, and the total amount of SCFAs was 350% (p < 0.0001) of that in the control group. Although the increases in acetate, propionate, and butyrate levels in the low ESG group were not significantly increased compared to those in the control group, the total amount of SCFAs was significantly (p = 0.031) increased to 186% of the control group.
Fig. 3 The amounts of cecal SCFAs were increased by ESG ingestion. Rats were fed high or low ESG diets for 2 weeks. The amounts of the SCFAs, acetate, propionate, and butyrate in the cecal content were measured with GLC as described in the materials and methods section. The total SCFA amount is the sum of the amounts of these 3 acids. Values are mean ± S.D.; n = 7. Bars with different letters are significantly different from each other (p < 0.05). |
All the above results strongly suggested that indigestible fractions of ESG were transferred to the cecum and assimilated by enteric bacteria. To examine this possibility, the concentrations of α-glucan and glucose in the cecal content and fecal samples were measured. As shown in Table 5, the concentration of α-glucan in the cecal content was significantly increased (more than 10-fold) in the high ESG group as compared to that in the control group (p = 0.0093), while the increase in the low ESG group (more than 2.6-fold) was not significant (p = 0.62) when compared to that in the control group. However, glucose concentrations in the cecal content of the high ESG (9.1 mg per g content) and low ESG groups (9.6 mg per g content) were significantly higher (p = 0.030 and p = 0.021, respectively) than that of the control group (3.6 mg per g content). The concentrations of α-glucan and glucose in the feces of the high ESG group were significantly increased to 878% and 244%, respectively, as compared to those in the control group. The amounts of excreted α-glucan in the feces of the control, high ESG and low ESG groups were estimated to be 0.06%, 0.48% and 0.13% of the carbohydrate intake, respectively.
Diet group | |||
---|---|---|---|
Control | High ESG | Low ESG | |
a Values are mean ± S D; n = 7. b The means in each row with different superscript letters are significantly different (p < 0.05). | |||
mg per g cecal content | |||
α-Glucan | 0.77 ± 0.50a | 8.0 ± 7.8b | 2.0 ± 1.9a |
Glucose | 3.6 ± 2.4a | 9.1 ± 5.0b | 9.6 ± 5.7b |
mg per g feces | |||
α-Glucan | 2.7 ± 1.7a | 23.7 ± 12.6b | 7.2 ± 2.5a |
Glucose | 3.6 ± 3.0a | 8.8 ± 1.0b | 2.8 ± 2.1a |
Diet group | |||
---|---|---|---|
Control | ESG | NSG | |
a Values are mean ± S D; n = 7. b The means in each row with different superscript letters are significantly different (p < 0.05). | |||
Cecal SCFA production (μmol per cecum) | |||
Acetate | 48.2 ± 24.1a | 230.1 ± 139.2b | 38.1 ± 11.4a |
Propionate | 16.0 ± 6.2a | 80.4 ± 43.6b | 14.5 ± 3.5a |
Butyrate | 10.1 ± 4.6a | 62.0 ± 29.0b | 14.5 ± 3.5a |
Cecal α-glucan (mg per g cecal content) | 0.54 ± 0.16a | 5.42 ± 7.12b | 0.28 ± 0.20a |
Epididymal fat (g) | 1.6 ± 0.2a | 1.1 ± 0.1b | 1.6 ± 0.3a |
Fig. 4 Weight and pH value of cecal content were altered by ESG but not NSG ingestion. Rats were fed ESG or NSG diets for 2 weeks. The cecal content was weighed (A) and pH was measured (B), as described in the materials and methods section. Values are mean ± S.D.; n = 7. Bars with different letters are significantly different from each other (p < 0.05). |
Diet group | ||
---|---|---|
Control | High ESG | |
a Values are mean ± S D; n = 7. b Mean values were significantly different from those of control group by Student's t-test (* p < 0.05, ** p < 0.01). | ||
Triacylglycerol (mg dL−1) | 86.2 ± 15.7 | 51.8 ± 11.7** |
Cholesterol | ||
Total (mg dL−1) | 62.2 ± 5.5 | 47.2 ± 4.2** |
HDL (mg dL−1) | 42.1 ± 3.1 | 34.2 ± 3.3** |
HDL/total ratio (%) | 67.8 ± 3.0 | 72.5 ± 2.8* |
NEFA (mEq L−1) | 0.68 ± 0.19 | 0.53 ± 0.12 |
We also carried out oral administration tests with NSG from mussel, which displayed the smallest molecular of α-amylase resistant fractions in an in vitro study.7 The quantity and pH of cecal contents were not altered after the rats ingested a diet containing 63% NSG from mussel for 2 weeks; and the amounts of α-glucan in the cecum was not increased (Table 6). Our previous study showed that the physicochemical properties of ESGs were equivalent to NSGs, but the fine structures of ESGs and NSGs were slightly different. In short, in the ESG molecule, the α-1,6-branch linkages were more regularly distributed than those in the NSG molecules.7 Consequently, most of spans between the branches in ESG molecules should be 1 or 2 glucose units, which can not be attacked by α-amylase.7 On the other hand, the spans in NSG molecules should be varied (0–4 units), and some parts with relatively long spans could be degraded. Thus, the difference should be related to the different resistant properties of ESGs and NSGs. However, the in vitro study showed that at least 1 out of 6 types of NSG possessed high molecular weight resistant fractions.7 It is possible that such NSGs having high resistance to α-amylase would be similarly metabolized in gut with ESG and affect lipid metabolism. We surmise that the molecular size of the resistant fractions of NSGs could be affected by the physiological conditions of organisms, such as their nutritional status; therefore, studies of the effects of ingestion of NSG with high molecular weight resistant fractions should be of great interest.
In this study, it was demonstrated that ESG ingestion affected lipid metabolism by decreasing plasma triacylglycerol, total cholesterol, and body fat accumulation, and increasing the HDL/total cholesterol ratio. These effects of ESG appeared to be similar to those of dietary fiber. However, the effects of fiber are known to be varied. Soluble fibers, pectin, guar gum, oat gum, and psyllium, reduced cholesterol concentrations in serum and liver, but did not change triacylglycerol concentration in cholesterol-fed SD rats.19 Epidemiological studies and dietary intervention studies have revealed that appropriate soluble dietary fiber lowers total and LDL cholesterol concentration without affecting HDL and triacylglycerol.8,13,20,21 However, a study in rodents revealed that resistant starch decreases both total serum cholesterol and triacylglycerol, with reduction of epididymal fat pad weight.22 Potato pulp, which is rich in resistant starch, also lowers serum cholesterol and triacylglycerol levels.23 Inulin and inulin-type fructans reduce plasma cholesterol as well as triacylglycerol levels through the downregulation of hepatic lipogenesis.24 In addition, Keenan et al.25 reported that consumption of a large amount of resistant starch reduced abdominal fat accumulation in rats. The mechanism underlying these effects of dietary fibers on lipid metabolism may be at least partly related to their viscosity and/or colonic fermentation. Thus, differences in colonic fermentation should contribute to different effects on lipid metabolism. Among the natural water-soluble fibers, resistant starch, inulin and inulin-type fructans have been recognized as major prebiotics,10–12 which are defined as nondigestible food ingredients that beneficially affect the host by selectively stimulating the growth and/or the activity of one or a few bacteria such as Bifidobacterium in the colon.26 In the present study, it was suggested that ESG ingestion increased intestinal Bifidobacterium and Lactobacillus. The effects of ESG on lipid metabolism and on the microbiota appeared to be similar to those of resistant starch, inulin and inulin-type fructans. Most studies evaluating the effects of dietary fiber on lipid metabolism have used diets containing 5%–10% dietary fiber. In this study, we used 63% and 17.8% ESG in the diet. Assuming that 20% of ESG could have a dietary-fiber like effect, these amounts could correspond to 12% and 3.5%, respectively, and were thus comparable with the amounts of dietary fiber in the previous studies. Interestingly, NSG from mussel did not affect lipid metabolism at all after a 2 week ingestion (data not shown). Thus, it was considered that the high molecular weight resistant fractions of ESG critically contribute to the observed effects on lipid metabolism.
This study demonstrated that ESG ingestion greatly increased SCFA production in the cecum. Acetate, a principal SCFA in the colon, has been reported to have favorable effects on energy metabolism.27–29 Acetate serves as a lipogenic substrate when incorporated into hepatocytes, whereas propionate is a competitive inhibitor of the transport of acetate into hepatocytes.30 With respect to cholesterol metabolism, propionate inhibits cholesterol synthesis, while acetate is the primary substrate for cholesterol synthesis.31 Thus, the increased ratio of propionate/acetate in the gut is likely to reduce the plasma triacylglycerol and cholesterol concentrations. It was reported that the molar proportion of cecal SCFA concentrations in rats fed a 65% cornstarch diet for 15 days is in the order of acetate > propionate > butyrate with an approximate molar ratio of 65:25:10.32 In this study, although the relative cecal concentrations of acetate, propionate, and butyrate in the control group were about 70:20:10, those in the high ESG group and low ESG group were about 48:26:26 and 60:18:22, respectively. Hence, we suggest that not only the increased SCFA quantities, but also the change in the ratios of individual SCFAs contribute to the effects on lipid metabolism.
A recent report revealed that SCFAs stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41, and propionate administration increases plasma leptin level in mice.33 Leptin is a well-known secretory hormone in adipose tissue, with anti-obesity properties; it is known to be related to the negative control of energy intake and the positive control of energy consumption.34 Although total SCFA production in the cecum was increased by more than 3-fold after ESG ingestion, the food intake was not affected in this study. In contrast, in our following study, plasma leptin concentration decreased slightly after ESG ingestion (unpublished data). This discrepancy can be explained on the basis of the reduction in the weight of subcutaneous adipose tissue that secretes leptin.34 Otherwise, acetate and propionate are reported to stimulate adipogenesis in adipocyte-like cell, 3T3-L1 cells.35 Further studies are warranted to clarify the mechanism of the anti-obesity effect of ESG.
ESG | Enzymatically synthesized glycogen |
NSG | Natural-source glycogen |
AUC | Area under the curve |
GLC | Gas/liquid chromatography |
SCFA | Short-chain fatty acid |
NEFA | Non-esterified fatty acids |
This journal is © The Royal Society of Chemistry 2011 |